Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3)-Reference-Cited by-同舟云学术

Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3)

Published:2019-09 Issue: Volume:74 Page:105700
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Wu Chaochen,Lin Haobo,Zhang Xiao

Funder

National Natural Science Foundation of China

Science and Technology Programme of Guangzhou, China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference34 articles.

1. Connective tissue disease-associated interstitial lung diseases: unresolved issues;Aparicio;Semin Respir Crit Care Med,2016

2. Rheumatoid arthritis-interstitial lung disease-associated mortality;Olson;Am. J. Respir. Crit. Care Med.,2011

3. Interstitial lung disease in connective tissue disease—mechanisms and management;Wells;Nat. Rev. Rheumatol.,2014

4. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis;Akhmetshina;Nat. Commun.,2012

5. Integrating mechanisms of pulmonary fibrosis;Wynn;J. Exp. Med.,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATF3 Modulates the Proliferation, Migration, and Apoptosis of Synovial Fibroblasts after Arthroscopy by Promoting RGS1 Transcription;Current Molecular Medicine;2023-11

2. Targeted Therapy in Rheumatoid-Arthritis-Related Interstitial Lung Disease;Journal of Clinical Medicine;2023-10-20

3. Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease;International Journal of Molecular Sciences;2023-09-25

4. Activating transcription factor 3: A potential therapeutic target for inflammatory pulmonary diseases;Immunity, Inflammation and Disease;2023-09

5. Promising small molecule anti-fibrotic agents: Newly developed or repositioned drugs targeting myofibroblast transdifferentiation;Biochemical Pharmacology;2023-08